{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:18:35Z","timestamp":1790468315122,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0160203","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T13:46:34Z","timestamp":1470404794000},"page":"e0160203","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae"],"prefix":"10.1371","volume":"11","author":[{"given":"Mohamed Ramadan","family":"El-Jade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Parcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda Maria","family":"Schmithausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Meilaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Molitor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6646-5888","authenticated-orcid":true,"given":"Isabelle","family":"Bekeredjian-Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"ref1","first-page":"881","article-title":"Betalactamases with broad activity spectrum","volume":"46","author":"W MM Witte","year":"2003","journal-title":"Principles, epidemiology and prevention of spread Bundesgesundheitsbl\u2014Gesundheitsforsch\u2014Gesundheitsschutz"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"DL Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijmm.2010.04.005","article-title":"Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens","volume":"300","author":"Y Pfeifer","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-0034-1398387","article-title":"Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum beta-lactamase and AmpC enzymes","volume":"36","author":"PN Harris","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1128\/AAC.01452-08","article-title":"In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa","volume":"53","author":"C Vidaillac","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/498519","article-title":"Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control","volume":"42","author":"J Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"E Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1586\/14787210.6.5.671","article-title":"Clinical significance of extended-spectrum beta-lactamases","volume":"6","author":"J Rodriguez-Bano","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"J Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"M Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","first-page":"1319","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia","volume":"60","author":"PD Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.00219-10","article-title":"Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues","volume":"48","author":"KS Thomson","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"R Leclercq","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"ref14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1469-0691.2007.01856.x","article-title":"Breakpoints for intravenously used cephalosporins in Enterobacteriaceae\u2014EUCAST and CLSI breakpoints","volume":"14","author":"G Kahlmeter","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref15","first-page":"156","article-title":"Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum beta-Lactamases","volume":"19","author":"J Curello","year":"2014","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"Suppl 1","key":"ref16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1469-0691.2007.01864.x","article-title":"Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam","volume":"14","author":"LR Peterson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1469-0691.2011.03673.x","article-title":"Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli","volume":"18","author":"J Rodriguez-Bano","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dks088","article-title":"Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?","volume":"67","author":"DM Livermore","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref19","first-page":"831074","article-title":"Clinical usefulness of the 2010 clinical and laboratory standards institute revised breakpoints for cephalosporin use in the treatment of bacteremia caused by Escherichia coli or Klebsiella spp","volume":"2015","author":"NS Ku","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/cid\/cis916","article-title":"Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters","volume":"56","author":"NY Lee","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/dkt450","article-title":"Determining a clinical framework for use of cefepime and beta-lactam\/beta-lactamase inhibitors in the treatment of infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"69","author":"HM Nguyen","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","article-title":"beta-lactam and beta-lactamase inhibitor combinations in the treatment of extended-spectrum beta-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?","volume":"15","author":"PN Harris","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1128\/AAC.01333-15","article-title":"The times they are a-changin': carbapenems for extended-spectrum-beta-lactamase-producing bacteria","volume":"59","author":"J Rodriguez-Bano","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1128\/AAC.04218-14","article-title":"In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized beta-lactamases","volume":"59","author":"P Levasseur","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jac\/dkh166","article-title":"Characterization of HMRZ-86: a novel chromogenic cephalosporin for the detection of extended-spectrum beta-lactamases","author":"H Hanaki","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jac\/dkm374","article-title":"Evaluation of the chromogenic Cica-beta-Test for detecting extended-spectrum, AmpC and metallo-beta-lactamases","volume":"60","author":"DM Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10156-007-0563-2","article-title":"Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs)","volume":"13","author":"H Hanaki","year":"2007","journal-title":"J Infect Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e0138173","DOI":"10.1371\/journal.pone.0138173","article-title":"Analysis of Transmission of MRSA and ESBL-E among Pigs and Farm Personnel","volume":"10","author":"RM Schmithausen","year":"2015","journal-title":"PLoS One"},{"key":"ref29","first-page":"10","article-title":"Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae","volume":"21","author":"CH Lee","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1128\/JCM.03614-13","article-title":"Rapid detection of beta-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic betaLacta test","volume":"52","author":"MI Morosini","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1128\/JCM.01629-14","article-title":"The beta-Lacta test for direct detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in urine","volume":"52","author":"S Gallah","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.31.20549","article-title":"Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011","volume":"18","author":"A Potron","year":"2013","journal-title":"Euro Surveill"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s10096-011-1523-4","article-title":"Cefotaxime for the detection of extended-spectrum beta-lactamase or plasmid-mediated AmpC beta-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia","volume":"31","author":"Y Matsumura","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.01523-12","article-title":"Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-beta-lactamase-producing bacteria","volume":"57","author":"FN Frakking","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1128\/AAC.00381-05","article-title":"Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species","volume":"50","author":"PJ Gavin","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1128\/JCM.00524-13","article-title":"Evaluation of the betaLACTA test, a novel commercial chromogenic test for rapid detection of ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates","volume":"51","author":"T Laurent","year":"2013","journal-title":"J Clin Microbiol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0198959","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0160203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T10:43:42Z","timestamp":1540291422000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0160203"}},"subtitle":[],"editor":[{"given":"Yung-Fu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":36,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0160203","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0198959","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}